Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Lisata Therapeutics (LSTA) Cash from Operations (2016 - 2025)

Lisata Therapeutics filings provide 13 years of Cash from Operations readings, the most recent being 3249000.0 for Q4 2025.

For the quarter ending Q4 2025, Cash from Operations rose 28.25% year-over-year to 3249000.0, compared with a TTM value of 15949000.0 through Dec 2025, up 17.6%, and an annual FY2025 reading of 15949000.0, up 17.6% over the prior year.
Cash from Operations hit 3249000.0 in Q4 2025 for Lisata Therapeutics, up from 3342000.0 in the prior quarter.
The five-year high for Cash from Operations was 2518000.0 in Q3 2024, with the low at 8196000.0 in Q1 2023.
Median Cash from Operations over the past 3 years was 4126500.0 (2023), compared with a mean of 4611416.67.
The sharpest move saw Cash from Operations increased 29.72% in 2024, then crashed 32.72% in 2025.
Year by year, Cash from Operations stood at 4069000.0 in 2023, then fell by 11.28% to 4528000.0 in 2024, then increased by 28.25% to 3249000.0 in 2025.
According to Business Quant data, Cash from Operations over the past three periods came in at 3249000.0, 3342000.0, and 3956000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.